---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-008450"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2024-05-20T23:59:59+00:00"
generated_at: "2026-06-01T13:11:22.717754+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Virios Therapeutics prices $1.7M public offering of 8.5M shares at $0.20/share for Long-COVID study prep

## Summary
- Priced public offering of 8,500,000 shares at $0.20 per share for gross proceeds of approx. $1.7M.
- Net proceeds to fund preparatory activities for planned IMC-2 Long-COVID Phase 2b study and general corporate purposes.
- Offering expected to close on May 22, 2024; Maxim Group LLC acting as sole placement agent.

## SEC filing metadata
- accession: 0001558370-24-008450
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2024-05-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000155837024008450/0001558370-24-008450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000155837024008450/viri-20240519x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-008450
- JSON: https://secwatch.observer/filing/0001558370-24-008450.json
- Plain text: https://secwatch.observer/filing/0001558370-24-008450.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.